{"id":"AGY-FED-HEALTH-OTHER-012","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to the Healthcare Distribution Alliance)","authority":"21 C.F.R. 1307.03; exception to 21 C.F.R. 1305.13 (transmission of paper DEA Form 222)","instrument":"DEA-DC-019 (DEA066), letter granting an exception permitting transmission of DEA Form 222 by fax or scan during the COVID-19 emergency","title":"Fax/Scan 222 (final) Esign","dateIssued":"2020-03-20","effective":"2020-03-20 (digitally signed Mar. 26, 2020)","end":"For the duration of the public health emergency","startDate":"2020-03-20","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"addressees":["registered distributors and purchasers of schedule I-II controlled substances"],"clause":"In light of the public health emergency declared by the Secretary of Health and Human Services on January 31, 2020, as a result of Coronavirus Disease 2019 (COVID-19) and the determination by the World Health Organization on March 11, 2020 that the global COVID-19 outbreak constitutes a pandemic, DEA will grant an exception to those provisions of 21 CFR 1305.13 that require the purchaser to submit the original DEA Form 222 to the supplier.","enforcement":"Order-form requirements under 21 U.S.C. 828 and 842(a)(5)","functions":["SC supply chain (controlled-substance ordering)","WH warehouse and shipping","OF administration under telework"],"notes":"Reached pharmaceutical distributors, hospital pharmacies and manufacturers whose purchasing staff worked remotely.","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-019)(DEA066)%20fax%20scan%20222%20(final)%20Esign.pdf","snapshot":"","fileExists":true,"fileBytes":180251,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-012","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-012","citation":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to the Healthcare Distribution Alliance), DEA-DC-019 (DEA066), letter granting an exception permitting transmission of DEA Form 222 by fax or scan during the COVID-19 emergency (Mar. 20, 2020) (Ex. AGY-FED-HEALTH-OTHER-012)","stateName":"","related":[]}